Kawai, Masaaki http://orcid.org/0000-0003-1383-0487
Ohtani, Shoichiro
Iwasaki, Motoki
Yamamoto, Seiichiro
Takamatsu, Kiyoshi
Okamura, Hitoshi
Arai, Masami
Nomura, Tsunehisa
Ozaki, Shinji
Shibata, Ken-ichi
Akabane, Ayaka
Motoi, Fuyuhiko
Yamauchi, Chikako
Yamamoto, Yutaka
Iwata, Hiroji
Saji, Shigehira
Article History
Received: 29 September 2023
Accepted: 27 November 2023
First Online: 26 December 2023
Declarations
:
: MK received honoraria for lectures from AstraZeneca, Chugai, Eisai, Eli Lilly and Company, Kyowa-Kirin, MSD, Novartis, and Pfizer; SO received honoraria for lectures from AstraZeneca, Chugai, Eizai and Eli Lilly; KT received honoraria for lectures from ASKA Pharmaceutical Co. Ltd., Bayer Yakuhin, Ltd., Fuji Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Tsumura & Co; YY received research funding from Chugai, Daiichi-Sankyo, Eisai, Kyowa-Kirin, Lilly, Nippon-Kayaku, Novartis, Pfizer, Taiho and Takeda; YY received honoraria for lectures from AstraZeneca, Chugai, Daiichi-Sankyo, Eisai, Exact Science, Kyowa-Kirin, Lilly, MSD, Nippon-Kayaku, Novartis, Pfizer, Sysmex, Taiho and Takeda; YY participated on advisory boards for AstraZeneca, Chugai, Daiichi-Sankyo, Lilly, MSD, Novartis and Pfizer; YY was a member of the board of directors of the Japanese Breast Cancer Society and Japan Breast Cancer Research Group; HI received grants from AstraZeneca, Chugai and Daiichi-Sankyo; HI received consulting fees from AstraZeneca, Chugai, Daiichi-Sankyo, Gilead, Lilly, MSD and Pfizer; HI received honoraria from AstraZeneca, Chugai, Daiichi-Sankyo, Kyowa Kirin, Lilly, MSD, Pfizer and Taiho; SS received grants from AstraZeneca, Chugai, Daiichi-Sankyo, Eisai, MSD and Taiho and Takeda; SS received honoraria from AstraZeneca, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Kyowa Kirin, MSD, Nipponkayaku, Novartis, Ono, Pfizer, Taiho and Takeda; SS participated on advisory boards for AstraZeneca, Chugai/Roche, Daiichi-Sankyo, Eli Lilly, Kyowa Kirin, MSD and Pfizer; SS was a member of the board of directors of Breast International Group (BIG), Japan Breast Cancer Research Group (JBCRG), Japanese Breast Cancer Society (JBCS) and Japanese Society of Medical Oncology (JSMO); MI, SY, HO, MA, TN, SO, KS, AA, FM, CY have no conflict of interest.